Mater Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health. Clinical trials are an essential component of healthcare. They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs.
Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.
Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.
Clinical Trials are divided into the following categories:
This study is trialing a novel drug, called JNT-517, which works by increasing excretion of phenylalanine in the urine to reduce circulating levels in the blood.
Trial Status:
Active, not recruiting
|
Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With Chronic obstructive pulmonary disease (COPD) and Chronic Bronchitis
ALT-100-002: Pioneering the Utility of eNAMPT-Reducing Therapies in Acute Respiratory Distress Syndrome [ARDS]/ ventilator-induced lung injury
Neuromodulation Using Scanning Ultrasound in Alzheimer’s Disease
This study is assessing the safety and effectiveness of a new anti-epileptic drug, called ganaxalone in patients admitted to the Intensive Care Unit with status epilepticus that has failed to respond to two other anti-epileptic medications.
Trial Status:
Active, not recruiting
|
The trial is testing a potential new treatment called disitamab vedotin for Muscle-invasive Bladder Cancer.
A clinical trial to test the effectiveness and safety of CVL-865 for treatment of drug-resistant focal onset epilepsy
A Phase 3 clinical study to investigate the use of benralizumab for patients with moderate to very severe chronic obstructive pulmonary disease (COPD)
Evaluating eptinezumab with a brief educational intervention for prevention of migraine in patients with migraine and medication overuse headache
Improve outcomes for women and small babies by improving blood flow to the baby in labour, to alleviate fetal distress.